Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain

This publication has 21 references indexed in Scilit:

• A review of the role of anti‐opioid peptides in morphine tolerance and dependence
  Synapse, 1992
• Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence
  Peptides, 1991
• FMRF-NH2-like mammalian octapeptide: Possible role in opiate dependence and abstinence
  Peptides, 1990
• Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain
  Peptides, 1990
• FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat
  Peptides, 1990
• Altered Expression of Hypothalamic Neuropeptide mRNAs in Food-Restricted and Food-Deprived Rats
  Neuroendocrinology, 1990
• IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice
  Peptides, 1989
• Implications of methadone maintenance for theories of narcotic addiction
  JAMA, 1988
• The action of FMRFamide (Phe-Met-Arg-Phe-NH2) and related peptides on mammals
  Peptides, 1988
• Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment
  Life Sciences, 1985